Temporary ATC/DDDs including alterations from the October 2020 meeting
Published Wednesday November 25 2020

Lists of temporary ATC codes, temporary DDDs and alterations decided at the latest meeting of the WHO International Working Group for Drug Statistics Methodology 15-16 October 2020 are now published on the website (Lists of temporary ATC/DDDs and alterations).

Please note the list of temporary DDDs in the new ATC 3rd level L01E Protein kinase inhibitors. The new ATC 3rd level L01E Protein kinase inhibitors is implemented in the 2021 ATC/DDD Index.

Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology before 1 February 2021. If no objections are received before this date, the new ATC codes, DDDs and alterations will be considered final and included in the January 2022 issue of the ATC/DDD Index.